cannabidiolic acid has been researched along with gsk0660 in 1 studies
| Studies (cannabidiolic acid) | Trials (cannabidiolic acid) | Recent Studies (post-2010) (cannabidiolic acid) | Studies (gsk0660) | Trials (gsk0660) | Recent Studies (post-2010) (gsk0660) |
|---|---|---|---|---|---|
| 76 | 1 | 68 | 55 | 0 | 45 |
| Protein | Taxonomy | cannabidiolic acid (IC50) | gsk0660 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor delta | Mus musculus (house mouse) | 0.048 | |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | 0.2099 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirao-Suzuki, M; Koga, T; Takeda, S; Takiguchi, M; Toda, A | 1 |
1 other study(ies) available for cannabidiolic acid and gsk0660
| Article | Year |
|---|---|
Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation.
Topics: Breast Neoplasms; Cannabinoids; Cyclooxygenase 2; Female; Gene Expression; Humans; PPAR delta; Signal Transduction; Sulfones; Thiazoles; Thiophenes; Transcription Factor AP-1; Tumor Cells, Cultured | 2020 |